Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | IDO1 | P14902 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.48 |
| ▸ | LTA4H | P09960 | 1/20 | 0.48 |
| ▸ | LAP3 | P28838 | 1/20 | 0.48 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.47 |
| ▸ | SLC1A2 | P43004 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.47 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.47 |
| ▸ | ALPI | P09923 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7419152 | 0.88 | SLC1A1 (0.60) | ALDH1A1SLC1A1KMT2AIDO1MAPK1 | |
| SCHEMBL7419155 | 0.88 | SLC1A1 (0.60) | ALDH1A1SLC1A1KMT2AIDO1MAPK1 | |
| Hydrochloric Acid SCHEMBL4704977 | 0.86 | ALDH1A1 (0.53) | ALDH1A1SLC1A1KMT2AIDO1MAPK1 | |
| SCHEMBL6119410 | 0.86 | ALDH1A1 (0.53) | ALDH1A1SLC1A1KMT2AIDO1MAPK1 | |
| Hydrochloric Acid SCHEMBL11024444 | 0.86 | SLC1A1 (0.59) | ALDH1A1SLC1A1KMT2AIDO1MAPK1 | |
| Hydrochloric Acid SCHEMBL25224887 | 0.86 | ALDH1A1 (0.53) | ALDH1A1SLC1A1KMT2AIDO1MAPK1 | |
| SCHEMBL1708893 | 0.86 | ALDH1A1 (0.53) | ALDH1A1SLC1A1KMT2AIDO1MAPK1 | |
| SCHEMBL6118400 | 0.86 | ALDH1A1 (0.53) | ALDH1A1SLC1A1KMT2AIDO1MAPK1 | |
| Hydrochloric Acid SCHEMBL20996762 | 0.86 | SLC1A1 (0.59) | ALDH1A1SLC1A1KMT2AIDO1MAPK1 | |
| SCHEMBL9544573 | 0.86 | CYP1A2 (0.53) | ALDH1A1SLC1A1KMT2AIDO1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210323908-A1 | PROCESS FOR PRODUCING TCA CYCLE INTERMEDIATE CONJUGATES | IMBRIA PHARMACEUTICALS, INC. | 2021-10-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210323908-A1 | PROCESS FOR PRODUCING TCA CYCLE INTERMEDIATE CONJUGATES | BCAT1, BCAT2, QPCT | ALDH1A1 395/4885SLC1A1 111/4885KMT2A 2524/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.